AB
AOI Biosciences, Inc.
Japan · Biotech
A biotechnology company developing antibody diagnostics and drug-discovery methods for difficult protein targets.
Two applications of molecular recognition
AOI Biosciences develops NeoSelf antibody tests, including a β2GPI test used in infertility and recurrent pregnancy-loss care. The company reports adoption at more than 300 Japanese medical institutions and expansion into other Asian markets.
Its drug-discovery work with Toshiba uses quantum-inspired optimization to investigate allosteric sites on proteins. These sites offer a way to influence a protein's activity away from its conventional binding location. AOI Biosciences is based in Ibaraki, Osaka.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Equity issuance and secondary transfer | Undisclosed | BIG Impact K2ファンド — ParticipantChushin Venture Capital Co., Ltd. — ParticipantGoAhead Ventures — Participanti-nest capital — ParticipantJapan Venture Capital Co., Ltd. — ParticipantOCP2号投資事業有限責任組合 — ParticipantSBI Shinsei Corporate Investment Co., Ltd. — ParticipantSeiho Investment Works Co., Ltd. — ParticipantSUMISEI INNOVATION FUND — Participant |